Heritage Wealth Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Heritage Wealth Advisors's NVS Position: Q1 2026 in Review
Heritage Wealth Advisors reduced its Novartis (NVS) stake by 72% in Q1 2026, selling an estimated $172K and leaving 436 shares worth $66.6K. The position accounts for ﹤0.01% of the portfolio, ranked #290.
Heritage Wealth Advisors first reported a position in NVS in Q3 2018 and has held it in 31 quarters since. The position peaked at $215K in Q4 2025. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Heritage Wealth Advisors held 436 shares of Novartis worth $66.6K as of Q1 2026.
- Heritage Wealth Advisors sold 1,120 Novartis shares in Q1 2026, an estimated $172K.
- Novartis made up ﹤0.01% of Heritage Wealth Advisors's portfolio in Q1 2026, its #290 holding.
- Heritage Wealth Advisors first reported a position in Novartis in Q3 2018 and has held it in 31 quarters since.
- Heritage Wealth Advisors's Novartis position peaked at $215K in Q4 2025.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Heritage Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.